AG931000: GlcNAcβ(1-4)GlcNAc-β-Propyl-PEG4-DBCO Pack Size:0.5 mg the innermost N-glycan residue with

the innermost N-glycan residue with the α1-6 core fucose that modulates antibody effector function and is a focus of biopharmaceutical glycoengineering

The installed glycan is a xylose residue (O-xylosylation)

/ Blood Group A Trisaccharide-Biotin / Biotinyl Blood Group A Trisaccharide

Fmoc-Ser(GlcNAc-β(1-6)(Gal β (1-3)GalNAc)-OH

α-D-Man-Propyl-Azide

AG931000: GlcNAcβ(1-4)GlcNAc-β-Propyl-PEG4-DBCO Pack Size:0.5 mg the innermost N-glycan residue withC49H70N6O17 1015. 1 A chitobiose (GlcNAc1 4GlcNAc) ligand equipped with a dibenzocyclooctyne (DBCO) handle through a propyl PEG4 spacer. The DBCO group reacts with azide functionalized partners via copper free strain promoted azide alkyne cycloaddition (SPAAC), forming stable 1,2,3 triazole linkages without a copper catalyst. This compound provides a chitobiose (GlcNAc1 4GlcNAc) building block, the core disaccharide of N linked glycans, useful for